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Abstract
Background: Fungal infection of the sclera is very rare. No case of fungal scleral abscess in a HIV-positive patient
has been reported. We report a case of scleral abscess caused by Candida albicans and its successful resolution
following antifungal therapy in a HIV-positive patient.
Findings: A 57-year-old diabetic Asian (Indian) who was on highly active antiretroviral therapy for the last 10 years
presented with 2 weeks’ history of redness in his right eye. Examination revealed localised scleral inflammation with
central ulceration in the inferior quadrant of the right eye. Initially, the ulcer scrapings revealed no microbial
organism. Progression of ulcer although on empirical antibiotic therapy required repeat scrapings which showed
Candida albicans species in culture sensitive to amphotericin and natamycin. Aggressive topical and systemic
antifungals resulted in dramatic and complete healing of the ulcer in 3 weeks. Vision was well maintained at 20/30
throughout the treatment course, and the fundus remained normal.
Conclusions: This is the first ever case of fungal scleral abscess in a HIV patient to be reported emphasizing there is
a need for high vigilance to suspect an infective aetiology of scleritis in patients with immunocompromised status.
Prompt microbial assessment and appropriate antifungals can decrease morbidity in these unusual but serious
cases as illustrated in this case.
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Findings
Introduction
Infections are uncommon causes of scleral inflammation
[1]. Diagnosis is often difficult and gets delayed as the
clinical picture appears similar to the more common
cause; the immune-mediated disease. Fungal infections of
the sclera have been reported following surgeries for ret-
inal detachment [2–5], pterygium [6, 7], cataract [8, 9]
and as a part of systemic fungal infections [10, 11]. All
these reports are in immunocompetent individuals with a
significant inflammatory response.
Acquired immune deficiency syndrome (AIDS) pa-
tients are prone to many opportunistic fungal infections,
but ocular fungal infections are rare and usually do not
involve the sclera [12]. We report a case of fungal scleral
abscess caused by Candida albicans in a patient with
AIDS and its successful resolution following antifungal
therapy.
Case report
A 57-year-old Asian (Indian) male was first seen at our
hospital in July 2015. He came to us with a history of red-
ness in his right eye for 15 days associated with pain and
watering. He had no complaints regarding his vision. He
was a known diabetic for 20 years and was detected to be
infected with human immunodeficiency virus (HIV)
10 years back. His CD4 count was 461cells/mm3 and was
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on highly active antiretroviral therapy (HAART). His
blood sugar levels were moderately controlled. There was
no history of trauma or any other significant history.
On examination, his best-corrected visual acuity
(BCVA) was 6/9, N6 in both eyes. Slit lamp examination
of the right eye revealed evidence of conjunctival conges-
tion and an oval scleral ulcerative lesion around 3 mm
posterior from the corneal limbus at around 6 o’clock me-
ridian, measuring 6 mm by 4.5 mm (Fig. 1). The ulcer had
dense infiltrates with a pseudomembrane. The cornea was
clear, and the anterior chamber was deep and quiet. Pos-
terior segment examination showed a clear vitreous and a
normal fundus. Left eye examination was within normal
limits. Intraocular pressure by applanation tonometry was
14 mmHg in both eyes. On systemic examination, there
was no Candida or any fungal infection elsewhere in the
body.
He was diagnosed as an infective scleral abscess of the
right eye. Scraping of the lesion was done and was put
on empirical treatment of oral indomethacin and topical
moxifloxacin eye drops one hourly.
Scraping did not reveal any fungal or bacterial ele-
ments, apart from occasional pus cells. He was advised
to continue medications. However, after 3 days, culture
on Sabouraud dextrose agar showed Candida albicans
species (Fig. 2.) which confirmed the clinical suspicion.
He was given amphotericin B 0.25 % eyedrops one
hourly, voriconazole 1 % eyedrops one hourly and cipro-
floxacin 0.3 % eyedrops four times per day along with
oral voriconazole 200 mg tablet twice daily. The patient
was continued on the same medication, while the lesion
started increasing in size.
Two days later, the scleral abscess showed signs of im-
provement. The epithelial defect and congestion per-
sisted. Culture and sensitivity were done which revealed
that the fungus is sensitive to amphotericin B and
natamycin and resistant to voriconazole, fluconazole and
itraconazole. Hence, topical natamycin was added and
voriconazole was stopped. The rest of the medications
were continued as earlier. The lesion started regressing,
and the patient was reviewed after 2 weeks.
At 2-week follow-up, his BCVA was 6/9, N6 in both
eyes. The patient had no fresh complaints. Slit lamp
examination revealed complete healing of the lesion
(Fig. 3). He was advised to stop topical and oral medica-
tions and was continued on only topical lubricants. At
1 month of follow-up, there was complete resolution of
the lesion. His viral load was increasing along with de-
crease in CD4 counts and was shifted to second line
HAART. At his last visit in January 2016, his viral load
was less than 150 copies/ml and was doing well on sec-
ond line HAART.
Fig. 1 Slit lamp photograph showing the scleral abscess
Fig. 2 Sabouraud dextrose agar (SDA) showing the isolates of
Candida albicans
Fig. 3 Slit lamp photograph showing completely resolved
scleral lesion
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Discussion
Fungal infections of the sclera are devastating cause of
infectious scleritis as they are difficult to diagnose and
often diagnosed late. The reported incidence of fungal
scleritis is around 11 to 38 % of the total infectious
causes of scleritis [13–15].
Candida albicans is a dimorphic commensal fungus.
Candidiasis is usually seen in immunocompromised in-
dividuals like HIV-infected patients. Candidiasis has a
varied presentation. Candida albicans usually causes
keratitis, chorioretinitis and endogenous endophthalmi-
tis in HIV/AIDS patients [16–18]. Scleral infection by
Candida albicans is very rare. Ahn et al. have reported
two cases of fungal scleral infection in immunocompe-
tent individuals [19]. Garelick et al. have described a case
of Cryptococcus albidus in a patient with AIDS [20].
No case of scleral abscess has been reported in any pa-
tient with HIV/AIDS. Our patient is a HIV-positive pa-
tient and has a scleral abscess caused by Candida
albicans. Hence, it should be considered as a possible
diagnosis and early investigation and treatment should
be done, as it can lead to devastating complication like
endophthalmitis. Our case also highlights the fact that a
strong degree of clinical suspicion backed by appropriate
anti-infective (anti-fungal) therapy is a must for the
complete resolution of the lesion.
Our case demonstrates the utility of culture and sensi-
tivity in choosing the appropriate anti-fungal agent, since
the initial use of a broad spectrum anti-fungal did not
yield the required result. Based on culture and sensitiv-
ity, specific drugs were used which lead to the complete
resolution of lesions.
Conclusion
In conclusion, we report an uncommon presentation of
a Candida albicans scleral abscess in an AIDS patient,
who was treated promptly by appropriate topical and
oral antifungals. Proper scraping and culture and sensi-
tive reporting are an essential component of diagnosis
and treating such a rare case thus preventing grave
consequences.
Consent
Written informed consent was obtained from the
patient.
Abbreviations
AIDS, acquired immune deficiency syndrome; HIV, human immunodeficiency
virus; HAART, highly active antiretroviral therapy; BCVA, best-corrected visual
acuity
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HS was involved in the data analysis and drafting of the manuscript. SS was
involved in patient interaction, diagnosis and in revising the manuscript
critically. LT helped in microbiological support and drafting of the
manuscript. MA was involved in patient interaction, diagnosis and in revising
the manuscript critically. JB was involved in patient interaction, diagnosis and
in revising the manuscript critically and gave final approval of the version to
be published. All authors read and approved the final manuscript.
Acknowledgements
We acknowledge the Departments of Uvea and Microbiology for their
support.
Received: 9 September 2015 Accepted: 8 June 2016
References
1. Watson PG (1995) Diseases of the sclera and episclera. In: Duane TD,
Jaegger EA (eds) Clinical ophthalmology, vol 4. JB Lippencott, Philadelphia,
pp 1–45
2. Lincoff HA, Mclean JM, Nano H (1965) Scleral abscess: a complication of
retinal detachment buckling procedures. Arch Ophthalmol 74:641–648
3. Milauskas AT, Duke JR (1967) Mycotic scleral abscess: report of a case
following a scleral buckling operation for retinal detachment. Am J
Ophthalmol 63:951–954
4. Bhermi G, Gillespie I, Manthalone B (2000) Scedosporium fungal infection of
a sponge explant. Eye 14:247–249
5. Kim JF, Perkins S, Harris GJ (2003) Voriconazole treatment of fungal scleritis
and epibulbar abscess resulting from scleral buckle infection. Arch
Ophthalmol 121:735–737
6. Lin CP, Shih MH, Tsai MC (1997) Clinical experience of infectious scleral
ulceration: a complication of pterygium operation. Br J Ophthalmol 81:980–983
7. Hsiao CH, Chen JJ, Huang SC et al (1998) Intrascleral dissemination of
infectious scleritis following pterygium excision. Br J Ophthalmol 82:29–32
8. Carlson AN, Foulks GN, Perfect JR et al (1992) Fungal scleritis after cataract
surgery. Successful outcome using itraconazole. Cornea 11:151–154
9. Mendicute J, Orbegozo J, Ruiz M et al (2000) Keratomycosis after cataract
surgery. J Cataract Refract Surg 26:1660–1666
10. Stenson S, Brookner A, Rosenthal S (1982) Bilateral endogenous necrotizing
scleritis due to Aspergillus oryzae. Ann Ophthalmol 14:67
11. Hemady R, Sainz Dela Maza M, Raizman M et al (1992) Six cases of scleritis
associated with systemic infection. Am J Ophthalmol 114:55
12. Waddell KM, Lucas SB, Downing RG (2000) Conjunctival cryptococcosis in
the acquired immune deficiency syndrome. Arch Ophthalmol 118:1452–
1453
13. Hodson KL, Galor A, Karp CL, Davis JL, Albini TA, Perez VL, Miller D, Forster
RK (2013) Epidemiology and visual outcomes in patients with infectious
scleritis. Cornea 32:466–472
14. Jain V, Garg P, Sharma S (2009) Microbial scleritis experience from a
developing country. Eye (Lond) 23:255–261
15. Kumar Sahu S, Das S, Sharma S, Sahu K (2012) Clinico-microbiological profile
and treatment outcome of infectious scleritis: experience from a tertiary eye
care center of India. Int J Infl am 2012:753560
16. Hemady R (1995) Microbial keratitis in patients infected with the human
immunodeficiency virus. Ophthalmology 102:1026–1030
17. Maenza JR, Merz WG (1998) Candida albicans and related species. In:
Gorbach SL, Bartlett JG, Blacklow NR (eds) Infectious diseases. W. B.
Saunders Company, Philadelphia, Pa, pp 2313–2322
18. Van Buren JM (1958) Septic retinitis due to Candida albicans. Arch Pathol
65:137
19. Ahn SJ, Oh JY, Kim MK et al (2010) Clinical features, predisposing factors,
and treatment outcomes of scleritis in Korean population. Korean J
Ophthalmol 24(6):331–335
20. Garelick JM, Khodabakhsh AJ, Lopez Y et al (2004) Scleral ulceration caused
by Cryptococcus albidus in a patient with acquired immune deficiency
syndrome. Cornea 23:730–731
Sharma et al. Journal of Ophthalmic Inflammation and Infection  (2016) 6:24 Page 3 of 3
